An electrode configured to adhere to a patient's skin to conduct electrical potentials therefrom includes a substrate, a skin adhesive configured to adhere the electrode to a patient's skin, and a conductor plate mounted on the substrate. A conductive gel is configured to contact the patient's skin and to conduct electrical potentials from the patient's skin to the conductor plate when the electrode is adhered to the patient's skin. A removable separator is positioned between the conductive gel and the conductor plate, wherein the removable separator is configured to be removed prior to operating the electrode to conduct electrical potentials.

In one aspect, an apparatus for monitoring a physiological condition of a patient is disclosed. The apparatus includes a body having an attachment portion configured to be inserted into the skin of a patient to affix the body to the patient. The apparatus includes a sensor coupled to the body that is configured to generate sensor data corresponding to a physiological condition of the patient when the body is secured to the skin of the patient. The apparatus further includes a reference sensor that is remote from the sensor coupled to the body and is configured to engage an outer surface of skin to generate reference data against which the sensor data is compared.

A method for reducing the risk of neurological injury to a neonatal human child includes the steps of: (I) monitoring in a pregnant patient during labor at least a first set of parameters indicative of a present level of risk for neurological injury to the child as a fetus; (II) during the period between a cervical dilatation of 10 cm in the patient and delivery of the child and/or during at least the first 5 minutes following delivery of the child, determining a present level of risk for neurological injury to the child based on the at least first set of parameters at a given point in time during labor that is between a cervical dilatation of 10 cm in the patient and delivery of the child, and wherein the determined present level of risk corresponds to one of a plurality of predetermined levels of predicted risk for neurological injury to the child as a neonate; and (III) commencing monitoring the child for one or more postnatal parameters indicative of neurological injury or its onset within the first 5 minutes following delivery of the child, and/or performing one or more measures for treating the child for neurological injury or its onset within the first 60 minutes following delivery of the child.

Exemplary embodiments of the present invention provide for an apparatus, computer-accessible medium, system and method for detection, analysis and use of fetal heart rate and movement. In accordance with certain exemplary embodiments of the present disclosure, an exemplary system can include: at least one electrocardiogram sensor providing first signals or information regarding the at least one subject; a plurality of inertial measurement units providing second signals or information regarding the at least one subject; a plurality of acoustic sensors providing third signals or information regarding the at least one subject; and a processor, wherein the processor is configured to determine data regarding the fetal heart rate based on the first, second and third signals or information.

A method and system are provided for detecting a position of a periodically moving organ in a MRI examination. MR images of an examining person including a periodically moving organ are provided over a plurality of periodic cycles of the periodically moving organ. Based on the provided MR images, a pixel frequency is associated with each pixel of the MR images. Using the associated pixel frequencies and the positions of the pixels within the MR images, the position and the frequency of the periodically moving organ are determined.

A technology for detecting fetal movement. In one example an electrocardiogram (ECG) dataset can be obtained where the ECG dataset contains fetal heart rate (FHR) values acquired from a pregnant subject, and the ECG dataset is for a segment of time during which an FHR is monitored using an ECG monitor. An FHR baseline can be calculated for the FHR values in the ECG dataset, and the ECG dataset can be analyzed to identify an accelerated FHR value that exceeds the FHR baseline that is followed in time in the ECG dataset by a decelerated FHR value that is less than or equal to the FHR baseline. Identifying the accelerated FHR value followed in time in the ECG dataset by the decelerated FHR value in the ECG dataset may indicate a fetal movement.

The present invention relates to a device for monitoring a concentration of an analyte in a foetus. The device comprises a biosensor for electrochemically measuring a concentration of an analyte in the foetus, a protrusion configured to be at least partially inserted into foetal tissue, and a device body supporting the biosensor and the protrusion. The device is configured such that when the device body contacts the surface area of the foetal tissue, the device body can be anchored to the foetal tissue and the protrusion can be inserted into the tissue so that the reactive substance of the biosensor electrochemically reacts with the analyte in the foetal tissue and in response to the electrochemical reaction the electrode of the biosensor detects an electronic signal, a strength of the electronic signal being indicative of the concentration of the analyte.

A decision support tool is provided for predicting the neonatal vitality scores of a fetus during delivery, the scores being an indicator of future health for the infant anticipated to be born within a future time interval, measured as time to birth. The predicted neonatal vitality score is determined from measurements of physiological variables monitored during labor, such as uterine activity and fetal heart rate. Fetal heart rate variability and patterns may be detected and computed using the monitored physiological variables, and neonatal vitality scores may be predicted based, at least in part, on the variability metrics and fetal heart rate patterns. Scores may be predicted for different delivery methods, such as vaginal delivery or cesarean delivery, for different time-to-birth intervals. In this way, these scores may be used for decision support for care plans during labor, such as increased monitoring and/or modifying the delivery type.

The invention provides systems and methods for monitoring the wellbeing of a fetus by the non-invasive detection and analysis of fetal cardiac electrical activity data.

A system for treating livestock may include a ramp for containing dairy livestock and one or more mobile units configured to travel on the ramp, below the dairy livestock, and milk the dairy livestock. A mobile unit may be adapted to travel to a predefined location within a stall, and attach a milking equipment unit to the dairy livestock in the stall. A plurality of mobile units and a central management unit may be configured to dynamically cause at least some of the plurality of mobile units to each perform a portion of a treatment or task.